Theravance Biopharma (TBPH) Change in Taxes (2014 - 2025)

Theravance Biopharma (TBPH) reported Change in Taxes of -$22.6 million for Q3 2025, down 7768.47% quarter-over-quarter from $295000.0 in Q4 2020.

Theravance Biopharma (TBPH) Change in Taxes (2014 - 2025) Analysis & Trends

Theravance Biopharma (TBPH) has 7 years of Change in Taxes data on file, last reported at -$22.6 million in Q3 2025.

Change in Taxes for Q3 2025 came in at -$22.6 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$22.7 million (changed N/A YoY), and the FY2020 annual result was $258000.0, down 93.03% from the prior year.
Change in Taxes declined to -$22.6 million in Q3 2025 per TBPH's latest filing, from $295000.0 in the prior quarter.
Over five years, Change in Taxes peaked at -$22.6 million in Q3 2025 and troughed at -$22.6 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change Taxes (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Theravance Biopharma	835.85 Mn	441.18 Mn	-	-

Download Data